These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33295723)

  • 21. COPD Exacerbator Phenotype is Inversely Associated with Current Smoking But Not with Haptoglobin Phenotype.
    Tal S; Adir Y; Stein N; Shalom H; Lache O; Levy A; Shteinberg M
    Isr Med Assoc J; 2019 Jan; 21(1):19-23. PubMed ID: 30685900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population.
    McGarvey L; Lee AJ; Roberts J; Gruffydd-Jones K; McKnight E; Haughney J
    Respir Med; 2015 Feb; 109(2):228-37. PubMed ID: 25613107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
    Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status.
    Fireman Klein E; Adir Y; Krencel A; Peri R; Vasserman B; Fireman E; Kessel A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():557-564. PubMed ID: 30880945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype.
    Geerdink JX; Simons SO; Pike R; Stauss HJ; Heijdra YF; Hurst JR
    Respir Res; 2016 Oct; 17(1):140. PubMed ID: 27793198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in cardiovascular risk and health-related quality of life in COPD patients according to clinical phenotype.
    Montiel AM; Ruiz-Esteban P; Del Río AD; Valdivielso P; Chaparro MÁS; Olveira C
    Sci Rep; 2024 Apr; 14(1):9687. PubMed ID: 38678074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype.
    Celli BR; Locantore N; Tal-Singer R; Riley J; Miller B; Vestbo J; Yates JC; Silverman EK; Owen CA; Divo M; Pinto-Plata V; Wouters EFM; Faner R; Agusti A;
    Eur Respir J; 2018 Feb; 51(2):. PubMed ID: 29437944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors Associated with the Non-Exacerbator Phenotype of Chronic Obstructive Pulmonary Disease.
    Bouhuis D; Giezeman M; Hasselgren M; Janson C; Kisiel MA; Lisspers K; Montgomery S; Nager A; Sandelowsky H; Ställberg B; Sundh J
    Int J Chron Obstruct Pulmon Dis; 2023; 18():483-492. PubMed ID: 37051115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.
    Omachi TA; Eisner MD; Rames A; Markovtsova L; Blanc PD
    Respir Res; 2011 Mar; 12(1):35. PubMed ID: 21429222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of Frequent Exacerbator Phenotype in Patients with Chronic Obstructive Pulmonary Disease.
    Krachunov I; Kyuchukov N; Ivanova Z; Yanev NA; Hristova PA; Pavlov P; Glogovska P; Popova T; Ivanov YY
    Folia Med (Plovdiv); 2018 Dec; 60(4):536-545. PubMed ID: 31188775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Serum Fractalkine/CX3CL1 in Patients with Chronic Obstructive Pulmonary Disease: Relationship with Emphysema Severity and Frequent Exacerbation.
    Hao W; Li M; Zhang C; Zhang Y; Xue Y
    Lung; 2019 Feb; 197(1):29-35. PubMed ID: 30382361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Serum Vitamin D (25OHD) Level with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Islam S; Sarkar NK; Mujahid AA; Bennoor KS; Hossain SS; Attar MM; Jahan R; Hossain MA; Chowdhury HA; Ali L
    Mymensingh Med J; 2019 Apr; 28(2):441-448. PubMed ID: 31086164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
    Wu Y; Qin J; He J; Shen Y; Wang H; Li Y; Zeng Q; Dong J; An Y; Xiong S; Feng M; Wen F
    Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COPD phenotypes: differences in survival.
    Hernández Vázquez J; Ali García I; Jiménez-García R; Álvaro Meca A; López de Andrés A; Matesanz Ruiz C; Buendía García MJ; de Miguel Díez J
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2245-2251. PubMed ID: 30050297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease.
    Schroeder JD; McKenzie AS; Zach JA; Wilson CG; Curran-Everett D; Stinson DS; Newell JD; Lynch DA
    AJR Am J Roentgenol; 2013 Sep; 201(3):W460-70. PubMed ID: 23971478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD.
    Li D; Wu Y; Guo S; Qin J; Feng M; An Y; Zhang J; Li Y; Xiong S; Zhou H; Zeng Q; Chen L; Wen F
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1933-1941. PubMed ID: 31695352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malnutrition, Airflow Limitation and Severe Emphysema are Risks for Exacerbation of Chronic Obstructive Pulmonary Disease in Japanese Subjects: A Retrospective Single-Center Study.
    Yamaya M; Usami O; Nakayama S; Tode N; Yamada A; Ito S; Omata F; Momma H; Funakubo M; Ichinose M
    Int J Chron Obstruct Pulmon Dis; 2020; 15():857-868. PubMed ID: 32368031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.